Actinium Pharmaceuticals logo

Actinium Pharmaceuticals

ATNM | AMEX
Chart Builder DCF Calculator
$1.49
-$0.15 (-9.15%)
At close: Nov 16, 2026, 4:00 PM ET
$1.42
-$0.07 (-4.37%)
After-hours: Nov 16, 2026, 6:06 PM ET
-9.15%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
82
Fundamentals Excellent
Market Sentiment Neutral
Moat None
Sector Rank #13/1021 (Top 1%)

Key Statistics

Market Data

Market Cap $46.85M
1D Range
1.47 1.68
52W Range
0.75 1.69

Valuation (TTM)

PE 4.14
PB 1.55
EV/EBITDA 0.96

Valuation (NTM)

Forward PE 9.11
Forward PEG -0.04
Price Target $4.95
Loading financial charts...

Profile

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing treatments, primarily focusing on those for bone marrow transplant (BMT) or other ...

Sector Healthcare
Industry Biotechnology
Employees 27
IPO Date Dec 27, 2012
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$4.95
Upside
+232.21%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.